[Federal Register: July 30, 1999 (Volume 64, Number 146)] [Notices] [Page 41447] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr30jy99-105] ----------------------------------------------------------------------- DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Initial Review Group Subcommittee D--Clinical Studies. Date: August 2-3, 1999. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Holiday Inn, 8777 Georgia Avenue, Silver Spring, MD 20910. Contact Person: Martin H. Goldrosen, MS, PhD, Scientific Review Administrator, Grants Review Branch, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6130 Executive Boulevard, Room 635C, Rockville, MD 20852- 7408, (301) 496-7930. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower, 93.399, Cancer Control, National Institutes of Health, HHS) Dated: July 26, 1999. LaVerne Y. Stringfield, Committee Management Officer, NIH. [FR Doc. 99-19506 Filed 7-29-99; 8:45 am] BILLING CODE 4140-01-M